comparemela.com

Latest Breaking News On - Insider transactions at olema pharmaceuticals - Page 1 : comparemela.com

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 8%

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 8%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cyrus-harmon
Group-plc
Securities-exchange-commission
Perceptive-advisors
Hedge-funds-weigh-in-on-olema-pharmaceuticals
News-ratings-for-olema-pharmaceuticals-daily
Vanguard-group-inc
Citigroup
Olema-pharmaceuticals-company-profile
Insider-transactions-at-olema-pharmaceuticals
Barclays-plc
Olema-pharmaceuticals-inc

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives $20.25 Consensus Target Price from Analysts

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives $20.25 Consensus Target Price from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
Cyrus-harmon
Analyst-recommendations-for-olema-pharmaceuticals
Nasdaq
News-ratings-for-olema-pharmaceuticals-daily
Credit-suisse-group
Jpmorgan-chase-co
Royal-bank
Citigroup-inc
Balyasny-asset-management
Olema-pharmaceuticals-inc
Virtu-financial

JPMorgan Chase & Co. Boosts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $16.00

JPMorgan Chase & Co. Boosts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $16.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Monaco
Cyrus-harmon
Prelude-capital-management
Credit-suisse-group
Insider-transactions-at-olema-pharmaceuticals
Sectoral-asset-management-inc
Olema-pharmaceuticals-inc
Olema-pharmaceuticals-trading-down
Analyst-recommendations-for-olema-pharmaceuticals
News-ratings-for-olema-pharmaceuticals-daily

Olema Pharmaceuticals (NASDAQ:OLMA) Coverage Initiated by Analysts at Oppenheimer

Equities research analysts at Oppenheimer started coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report) in a research note issued to investors on Thursday, FlyOnTheWall reports. The brokerage set an “outperform” rating on the stock. Several other equities research analysts have also commented on OLMA. Lifesci Capital reiterated an “outperform” rating on shares […]

Cyrus-harmon
Olema-pharmaceuticals-company-profile
Olema-pharmaceuticals-inc
News-ratings-for-olema-pharmaceuticals-daily
Olema-pharmaceuticals
Insider-transactions-at-olema-pharmaceuticals
Olema-pharmaceuticals-price-performance
Renaissance-technologies
Acadian-asset-management
Institutional-trading-of-olema-pharmaceuticals
Prelude-capital-management
Blackrock-inc

vimarsana © 2020. All Rights Reserved.